Literature DB >> 32866632

Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: Single center experience.

Guo-Long Zhang1, Uma Keyal2, Lei Shi1, Pei-Ru Wang1, Ling-Lin Zhang1, Anil Kumar Bhatta2, Yu-Hao Wu1, Shan Fang1, Xiu-Li Wang3.   

Abstract

The aim of this study was to demonstrate the efficacy of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) as an alternative treatment in cutaneous squamous cell carcinoma (cSCC) patients who are not fit for surgery. Thirty-three invasive cSCC patients who, for some reasons, cannot undergo surgery were enrolled in this study. All patients received plum blossom needle (PBN) pretreated ALA-PDT combined with topical application of 5% imiquimod cream. Two patients dropped the study because of severe pain and two patients discontinue treatment due to lack of response. Of 29 patients, who completed the treatment, 5 patients had complete response after 2-9 sessions of PDT and these patients had no recurrence till 18 months after treatment. Twenty-four patients achieved partial response and are satisfied with treatment outcome in terms of decreased symptoms and improved quality of life. PBN pretreated PDT in combination with topical imiquimod may be a viable treatment option for non resectable cSCC lesions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Imiquimod; Invasive squamous cell carcinoma; Photodynamic therapy; Plum blossom needle

Mesh:

Substances:

Year:  2020        PMID: 32866632     DOI: 10.1016/j.pdpdt.2020.101980

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  2 in total

1.  An insight into photodynamic therapy towards treating major dermatological conditions.

Authors:  Anuradha Dey; Gautam Singhvi; Anu Puri; Prashant Kesharwani; Sunil Kumar Dubey
Journal:  J Drug Deliv Sci Technol       Date:  2022-08-30       Impact factor: 5.062

2.  PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma.

Authors:  Qingyu Zeng; Jiayi Yang; Jie Ji; Peiru Wang; Linglin Zhang; Guorong Yan; Yuhao Wu; Qi Chen; Jia Liu; Guolong Zhang; Xiuli Wang
Journal:  Oncoimmunology       Date:  2022-04-03       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.